Giuseppe Giannini

15PUBLICATIONS
92CO-AUTHORS
Molecular targetsLiquid biopsiesAutoimmunityGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 30, 2025
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Paolo Marchetti, Giuseppe Curigliano, Mauro Biffoni

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

|Jan 06, 2025
IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes.

Rocco Amendolara, Luca D'Onofrio, Rosario Luigi Sessa

|Dec 18, 2024
SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation.

Fabio Bordin, Gloria Terriaca, Adriano Apostolico

|Sep 21, 2024
MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation.

Rosa Bordone, Devon Michael Ivy, Rodrigo D'Amico

|Apr 13, 2024
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors.

Valentina Magri, Gianluigi De Renzi, Luca Marino

Pageof 3

Frequent Collaborators

3 joint publications

Enrico De Smaele

3 joint publications

Marta Moretti

3 joint publications

Gianluca Canettieri

3 joint publications

Paola Gazzaniga